Dr Nigel Scott
Global Head of Regulatory Affairs
Dr. Nigel Scott is Celixir’s Global Head of Regulatory Affairs. Dr. Scott holds a MB, Bchir from the University of Cambridge, and a PhD in Protein Biochemistry from the University of London. Dr. Scott has held increasingly senior regulatory affairs positions in Bristol Myers Squibb, AstraZeneca, Fulcrum Pharma and most recently Daiichi Sankyo, where he was the Senior Director for Regulatory Affairs for Europe. At Daiichi Sankyo, he was the Regulatory lead for the Cardiovascular and Frontier Opportunities Therapeutic Areas, and was responsible for all European interactions with EU Competent Authorities. The main areas of development he has gained experience in are: Cardiovascular disease, diabetes, metabolic disorders and pain.